• About Us
  • Our Products
  • Distributors
  • Technology
  • Investors
  • News Center
  •  
  •  

Diaxonhit, the leading French provider of specialty in vitro diagnostics and life-science solutions.

 

Navigation

  • Our Products
    • Portfolio
    • Pathologies
    • Collaborations
    • Scientific Communications

Languages

  • English
  • Français

Print

  • CLICK HERE TO PRINT
  • CLICK HERE TO
    DOWNLOAD AS PDF
Send this article
 


 
Home » Our Products
 » Scientific Communications
Scientific Communications

 

You will find here articles, posters, in french and in english concerning our products in diagnosis and the company's proprietary technologies.
 

> BJI InoPlex™

> AlloMap®
>  Publications on hGWSA microarray 
 

 

BJI InoPlex™ 

 
PUBLICATIONS
 
  • Marmor et al. Multiplex Antibody Detection for Noninvasive Genus-Level Diagnosis of Prosthetic Joint Infection. J. Clin. Microbiol. 2016 Apr ; 54(4):1065-73.
 
  • Comparative serologic proteome analysis of Staphylococcus aureus and S. epidermidis exoproteins in prosthetic joint infections, Nuyttens et al, Pathologie Biologie 59 (2011) 1–8 PMID: 20850230
 
ABSTRACTS AND POSTERS
 
  • 35th EBJIS 2016 – Oxford, United Kingdom – 1-3 September, 2016
Contribution of a multiplex serological immunoassay to the preoperative documentation of prosthetic joint infection
 
  • 116th ASM – Boston, Massachusetts – 16-20 June, 2016
Routine use of a multiplex serological assay in the management of prosthetic infection
 
  • 26th ECCMID – Amsterdam, Netherlands – 9-12 April, 2016
Evaluation of BJI InoPlex test for diagnosis of prosthetic joint infection in one French reference centre.
  
  • 35th RICAI 2015 – Paris, France – 14-15 December, 2015
Evaluation de l’intérêt diagnostique du test BJI Inoplex chez des patients ayant une suspicion d’infection sur prothèse ostéo-articulaire (IPOA): évaluation prospective dans un service de microbiologie 
 
  • 34th EBJIS 2015 – Estoril, Portugal – 10-12 September, 2015
A Novel Serological ImmunoAssay For The Genus Level Diagnosis Of Prosthetic Joint Infection: A Prospective Study
 
  • 2ème Congrès National des CRIOAC – 3-4 September, 2015
Evaluation de l’intérêtdiagnostique du test BJI InoPlex® chez des patients ayantune suspicion d’infection sur prothèseostéo‐articulaire (IPOA) : évaluation prospective dans un service de Microbiologieassocié à un CRIOA
 
  • 115th ASM – New Orleans, Louisiana – 30 May-2 June, 2015
BJI Inoplex, a Novel Serological Assay for the Genus Level Diagnosis of Prosthetic joint Infection: a Prospective Study
 
  • 25th ECCMID – Copenhagen, Danemark – 25-28 April, 2015
Validation of a multiplex serological immunoassay for the non-invasive diagnosis of prosthetic joint infections. A non-interventional prospective study. 
 
 BACK TO TOP
 

AlloMap®

 

AlloMap and Heart Transplantation Basics

  • Dedrick R. Understanding Gene Expression Patterns in Immune-Mediated Disorders. J Immunotox. 2007 Jul;4(3):201-207.
  • Fang K. Clinical Utilities of Peripheral Blood Gene Expression Profiling in the Management of Cardiac Transplant Patients. J Immunotox. 2007 Jul;4(3):209-217.
  • Hunt SA and Haddad F. The Changing Face of Heart Transplantation. J. Am. Coll. Cardiol. 2008;52: 587-598.


 

AlloMap Test Performance Characteristics and Decision Impact

  • Pham MX, Teuteberg, JJ, Kfoury, AG et al. Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation. N Engl J Med 2010; 362:1890-1900.


 

AlloMap recommended in ISHLT guidelines

  • Costanzo MR, Dipchand A, Starling RC et al., The International Society of Heart and Lung Tranplantation Guidelines for the care of Heart Transplant Recipients. J Heart Lung Transplant. 2010;29 (8):914-956.


 

Health Economics (in the US)

  • Evans RW, Williams GE, Baron HM, et al. The economic implications of noninvasive molecular testing for cardiac allograft rejection. Am J Transplant. 2005 Jun;5(6):1553-8.


 

Key AlloMap Clinical Trials and Studies

  • Crespo-Leiro MG, Zuckermann A, Bara C, Mohacsi P, Schulz U, Boyle A et al. Concordance Among Pathologists in the Second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II). Transplantation 2012;94(11):1172-1177.
  • Gene Expression Profiling as a Noninvasive Method to Monitor for Cardiac Allograft Rejection. Technol Eval Cent Assess Program Exec Summ. 2011 Nov;26(8):1-3.
  • Pham MX, Teuteberg, JJ, Kfoury, AG et al. Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation. N Engl J Med 2010; 362:1890-1900.
    Supplementary Appendix. Pham MX et al. Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation.
  • Deng MC, Eisen HJ, Mehra MR, et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant. 2006 Jan;6(1):150-160.

 

 

For more publication click here: CareDX  AlloMap

 

 

BACK TO TOP

 
 

Publications on hGWSA microarray 

 
  • Matthew P. Pando, Jennifer Carrière, Laurent Désiré, Pascale Beurdeley, Isabelle Barber Exonhit SA, Paris, France
    Microarray-based transcriptomic signatures to help improving the success rate of clinical trials
    Poster presented during CTAD  - November 2011  pdf
 
  • Einstein. R,Commentary on ‘‘developing a national strategy to prevent dementia: Leon Thal Symposium 2009.’’ Developing a blood test for Alzheimer’s disease using advanced genomic expression technology Alzheimers Dement.2010 Mar;6(2):147-9 PMID:20298978
 
 
  • André F, Michiels S, Dessen P, Scott V, Suciu V, Uzan C, Lazar V, Lacroix L, Vassal G, Spielmann M, Vielh P, Delaloge S, Exonic expression profiling of breast cancerand benign lesions: a retrospective analysis
    Lancet Oncol. 2009 Apr;10(4):381-90. Epub 2009 Feb 25 PMID:19249242
  

 

  • Fabrice André, Olivier Sol, Pascale Beurdeley, Raphaël Haddad, Jennyfer Carrière, Véronique Scott, Suzette Delaloge, Philippe Vielh ; VALIDATION OF A MOLECULAR SIGNATURE (EHT Dx14) ON FINE-NEEDLE ASPIRATE SAMPLES FROM BREAST TUMORS 
    Poster presented during the WIN congress 6th-8th July 2011 pdf

 

 

  • Suzette Delaloge, Fabrice André, Pascale Beurdeley, Olivier Sol, Raphaël Haddad, Véronique Scott, Jennyfer Carrière, Corinne Balleyguier, Catherine Uzan, Philippe Vielh. Institut de Cancérologie Gustave Roussy, Villejuif, France, Exonhit SA, Paris, France
    Validation d’une signature transcriptomique (EHT Dx14) sur des échantillons de tumeurs mammaires prélevés par cytoponction à l’aiguille fine.
    Poster presented during SFSPM congress - November 2011 pdf

 

BACK TO TOP

 

 

Site map - © 2009-2017 Diaxonhit. All Rights Reserved - Legal information -